Christina Gloeckel

Title: Christina Gloeckel: Innovator in Cystic Fibrosis Treatment

Introduction

Christina Gloeckel is a prominent inventor based in Vienna, Austria. She has made significant contributions to the field of medical science, particularly in the treatment of cystic fibrosis. Her innovative work has led to the development of a unique composition aimed at improving the lives of those affected by this condition.

Latest Patents

Christina Gloeckel holds one patent titled "Composition for the treatment of cystic fibrosis." This invention provides a composition that includes at least one prostacyclin or prostacyclin analog, along with a phosphodiesterase (PDE) 4 inhibitor. The composition is designed to selectively increase cAMP levels in bronchoepithelial cells, thereby preventing or treating cystic fibrosis.

Career Highlights

Gloeckel's career is marked by her dedication to advancing medical treatments. She works at Scipharm Sarl, where she collaborates with other experts in the field. Her innovative approach and commitment to research have positioned her as a key figure in the development of therapies for cystic fibrosis.

Collaborations

Christina has worked alongside notable colleagues, including Michael Freissmuth and Xaver Koenig. Their combined expertise has contributed to the success of her research and the advancement of treatment options for cystic fibrosis.

Conclusion

Christina Gloeckel's contributions to the treatment of cystic fibrosis through her innovative patent demonstrate her commitment to improving patient outcomes. Her work continues to inspire advancements in medical science and offers hope to those affected by this challenging condition.